首页> 外国专利> Therapeutic or prophylactic agent for urinary frequency or urinary incontinence or a pharmaceutically acceptable acid addition salt thereof, method for urinary frequency therapy or prophylaxis, urinary urgency or urinary incontinence, use of a morphine derivative having a nitrogen-containing heterocyclic group or a pharmaceutically acceptable acid addition salt thereof, morphine derivative or a pharmaceutically acceptable acid addition salt thereof, pharmaceutical, and pharmaceutical composition

Therapeutic or prophylactic agent for urinary frequency or urinary incontinence or a pharmaceutically acceptable acid addition salt thereof, method for urinary frequency therapy or prophylaxis, urinary urgency or urinary incontinence, use of a morphine derivative having a nitrogen-containing heterocyclic group or a pharmaceutically acceptable acid addition salt thereof, morphine derivative or a pharmaceutically acceptable acid addition salt thereof, pharmaceutical, and pharmaceutical composition

机译:尿频或尿失禁的治疗剂或预防剂或其药学上可接受的酸加成盐,尿频治疗或预防的方法,尿急或尿失禁,使用具有含氮杂环基的吗啡衍生物或药学上可接受的酸其加成盐,吗啡衍生物或其药学上可接受的酸加成盐,药物和药物组合物

摘要

"THERAPEUTIC OR PROPHYLATIC AGENT FOR URINARY FREQUENCY, OR URINARY INCONTINENCE OR ITS PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT, METHOD FOR URINARY URINARY TREATMENT OF URINARY DYNAMICS, NITROGEN OR ITS PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT, MORPHINE DERIVATIVE OR ITS PHARMACEUTICALLY ACID ADDITION SALT, PHARMACEUTICAL PRODUCT, AND, PHARMACEUTICAL COMPOSITION ". The invention provides a derivative of Formula (I): wherein R1 is methyl, cyclopropylmethyl or the like; R2 and R3 are hydroxy, methoxy, acetoxy or the like; both Y and Z are valence bonds, -C (= O) - or others; X is C 2 -C 5 carbon chain (one of the carbon atoms which may be substituted by oxygen, sulfur or nitrogen) constituting a part of the ring structure, or the like; (R 4 R 4) k is substituted or unsubstituted benzene fused ring, carbonyl group or the like; is hydrogen or others; R 10 and R 11 are bound to represent -O- or the like, and R 6 is hydrogen or the like or a pharmaceutically acceptable acid addition salt thereof. The invention also provides a therapeutic or prophylactic agent for urinary frequency or urinary incontinence, comprising as an effective ingredient the morphine derivative or pharmaceutically acceptable acid addition salt thereof; a method for disease therapy or prophylaxis, and use against disease. The compounds of the invention are useful as a novel therapeutic or prophylactic agent for urinary frequency or urinary incontinence, free of side effects, and useful for the method for disease therapy or prophylaxis and for use against diseases.
机译:“尿频的治疗或促发剂,或尿沉着性或其药学可接受的酸添加盐,尿动力学,尿或其动力学的尿常规处理方法,氮或其药学上可接受的酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的,酸性的。和,“药物成分”。本发明提供了式(I)的衍生物:其中R 1为甲基,环丙基甲基等; R 2和R 3为羟基,甲氧基,乙酰氧基等; Y和Z均为价键,-C(= O)-或其他; X为构成环结构的一部分等的碳原子数为2〜5的碳链(可以被氧,硫或氮取代的碳原子之一)。 (R 4 R 4)k为取代或未取代的苯稠环,羰基等。是氢或其他; R 10和R 11结合表示-O-等,并且R 6是氢等或其药学上可接受的酸加成盐。本发明还提供了尿频或尿失禁的治疗剂或预防剂,其包含吗啡衍生物或其药学上可接受的酸加成盐作为有效成分。一种疾病治疗或预防方法,以及用于预防疾病的方法。本发明的化合物可用作尿频或尿失禁的新型治疗剂或预防剂,无副作用,并可用于疾病治疗或预防方法以及用于疾病治疗。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号